Skip to Main content Skip to Navigation
Conference papers

TALISMAN Transnational Access to Key Nuclear Research Facilities in Europe

Abstract : Actinides studies require specific hot laboratories and characterization tools that are only available in a limited number of places worldwide. Actually, only a few academic and research organisations have the capabilities to work on these elements under safe conditions in Europe. To ensure a sustaining development of actinides sciences, it is therefore considered as a strategic issue to coordinate the existing actinide infrastructures available in Europe, and to strengthen the community of European scientists working on actinides.Since 2004, Europe supports the strengthening of the European actinides sciences scientific community through the funding of dedicated networks. In this continuation, TALISMAN (Transnational Access to Large Infrastructures for a Safe Management of ActiNides) gathers now the main European hot laboratories in actinides sciences in order to promote their opening to academics and universities and strengthen the EU-skills in actinides sciences. Furthermore, a specific focus is set on the development of advanced cutting edge experimental and spectroscopic capabilities, the combination of state-of-the art experimental with theoretical first-principle methods on a quantum mechanical level and to benefit from the synergy between the different scientific and technical communities The paper comes back on more than 10 years of successful collaboration in this field in Europe and present TALISMAN in more details
Complete list of metadatas

https://hal-cea.archives-ouvertes.fr/cea-02489551
Contributor : Amplexor Amplexor <>
Submitted on : Monday, February 24, 2020 - 2:56:34 PM
Last modification on : Tuesday, April 28, 2020 - 11:28:17 AM

Identifiers

  • HAL Id : cea-02489551, version 1

Collections

CEA | DEN

Citation

S. Bourg, C. Poinssot. TALISMAN Transnational Access to Key Nuclear Research Facilities in Europe. E-MRS, May 2015, Lille, France. ⟨cea-02489551⟩

Share

Metrics

Record views

11